← Leaderboards
Daniel Meier
Pharmacophotonics, Inc.
$2,107,712
Attributed
$4,215,424
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–17$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,215,424 · 1
By mechanism
R44$4,215,424 · 1
Top collaborators
- Bruce A Molitoris5 shared
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingEvaluationEnd Stage Renal FailureFluorescenceEquationEquilibriumDoseDisease ProgressionDevicesEarly DiagnosisAdoptedChronic Kidney FailureClinical ApplicationBloodBlood Plasma VolumeAcuteAcute Renal Failure With Renal Papillary NecrosisDiagnosisCanis FamiliarisAnimal ModelCreatinineCaringBaseGlomerular Filtration Rate
Grant awards (5)
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$997,989
R44 · FY2017 · DK · contact PI
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$999,405
R44 · FY2016 · DK · contact PI
Clinical and Non-Clinical Evaluations of repeat administrations of the FAST PV and mGFR Technology$999,701
R44 · FY2015 · DK · contact PI
Clinical Trial of the FAST Real-Time GFR System$1,045,698
R44 · FY2014 · DK · contact PI
Clinical Trial of the FAST Real-Time GFR System$172,631
R44 · FY2011 · DK · contact PI